Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;65(12):1678-9.
doi: 10.1136/ard.2006.056176.

Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis

S Rajakulendran, K Gadsby, D Allen, S O'Reilly, C Deighton

Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis

S Rajakulendran et al. Ann Rheum Dis. 2006 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ledingham J, Deighton C. Update on the British Society of Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 200544157–163. - PubMed
    1. Furst D E, Breedveld F C, Kalden J R, Burmester G R, Smolen J S, Bijlsma J W J.et al Updated consensus on biological agents, specifically tumour necrosis factor α, (TNFα) blocking agentsand interleukin‐1 receptor antagonist (IL‐1ra), for the treatment of rheumatic diseases. Ann Rheum Dis 200564iv2–NaN14. - PMC - PubMed
    1. Markham A, Lamb H M. Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs 2000591341–1359. - PubMed
    1. Jarvis B, Faulds D. Etanercept: a review of its use in rheumatoid arthritis. Drugs 199957945–966. - PubMed
    1. Vidal F, Fontova R, Richart C. Severe neutropaenia and thrombocytopaenia associated with infliximab. Ann Intern Med 200313963 - PubMed

MeSH terms